Ashley Ghiaseddin
University of Florida
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ashley Ghiaseddin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06558214 · OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialUniversity of Florida · recruiting · Recurrent Glioblastoma · principal investigator
- Ph1NCT06389591 · RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)University of Florida · active not recruiting · Recurrent Glioblastoma · principal investigator
- Ph1NCT06254326 · ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsUniversity of Florida · active not recruiting · Recurrent Oligodendroglioma, Progressive Oligodendroglioma · principal investigator
- Ph1NCT05353530 · IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GlioblastomaUniversity of Florida · active not recruiting · Glioblastoma Multiforme, Glioblastoma · principal investigator
- Ph1NCT04963413 · RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.University of Florida · terminated · Glioblastoma · principal investigator
- Ph2NCT03405792 · Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)University of Florida · active not recruiting · Glioblastoma, Glioblastoma, WHO Grade IV · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Overcoming the blood-brain barrier with nanoparticle vaccines against gliomasR37CA251978 · NCI · UNIVERSITY OF FLORIDA · PI Elias Sayour · fiscal years 2021 to 2026Named on NCT06389591
Most cited trial papers
Clinical-trial papers with this author name in glioma, ranked by citations from NIH iCite, fetched 2026-11-12 13:31 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed